Elizabeth Czerepak's Net Worth
$0
Who is Elizabeth Czerepak?
Elizabeth Czerepak does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ADVANCIS PHARMACEUTICAL CORP, HEALTHCARE ACQUISITION CORP, Sorrento Therapeutics, Inc., SPECTRUM PHARMACEUTICALS INC, DELCATH SYSTEMS, INC., CANCER GENETICS, INC, Scilex Holding Co, and AFFYMAX INC.
SEC CIK
Elizabeth Czerepak's CIK is 0001263500
Past Insider Trading and Trends
2017 was Elizabeth Czerepak's most active year for acquiring shares with 4 total transactions. Elizabeth Czerepak's most active month to acquire stocks was the month of April. 2006 was Elizabeth Czerepak's most active year for disposing of shares, totalling 2 transactions. Elizabeth Czerepak's most active month to dispose stocks was the month of November. 2022 saw Elizabeth Czerepak paying a total of $0.00 for 359,000 shares, this is the most they've acquired in one year. In 2006 Elizabeth Czerepak cashed out on 1,159,551 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ADVANCIS PHARMACEUTICAL CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
∞
| 2.43M |
—
|
—
| 2.43M |
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HEALTHCARE ACQUISITION CORP (ALT) Snapshot price: $6.21
CFO and EVP Corp. Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 9
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sorrento Therapeutics, Inc. (SRNEQ) Snapshot price: $0.01
EVP & Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SPECTRUM PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +300.00% | 30K |
—
|
—
| 40K |
Jun 18
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
Jun 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DELCATH SYSTEMS, INC. (DCTH) Snapshot price: $10.36
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||